Author Index

Search or browse for an author across our entire electronic archive

Search results for: O
Results 21 - 30 of 688 shown below

  • O'Neill, P A

    P A O'Neill, A M Shaaban, C R West, A Dodson, C Jarvis, P Moore, M P A Davies, D R Sibson and C S Foster

    Increased risk of malignant progression in benign proliferating breast lesions defined by expression of heat shock protein 27

    doi:10.1038/sj.bjc.6601449

  • O'Neill, V J

    V J O'Neill, S B Kaye, N S Reed, J Paul, J A Davis and P A Vasey

    A dose-finding study of carboplatin-epirubicin-docetaxel in advanced epithelial ovarian cancer

    doi:10.1038/sj.bjc.6600259

  • V J O'Neill and C J Twelves

    Oral cancer treatment: developments in chemotherapy and beyond

    doi:10.1038/sj.bjc.6600591

  • O'Nions, J

    L A Brooks, A Sullivan, J O'Nions, A Bell, B Dunne, J A Tidy, D J Evans, P Osin, K H Vousden, B Gusterson, P J Farrell, A Storey, M Gasco, T Sakai and T Crook

    E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia

    doi:10.1038/sj.bjc.6600033

  • O'Reilly, S

    A P McGlynn, G R Wasson, S O'Reilly, V J McKelvey-Martin, H McNulty, J J Strain, G McKerr, F Mullan, N Mahmud, J Scott, D G Weir and C S Downes

    Detection of replicative integrity in small colonic biopsies using the BrdUrd comet assay

    doi:10.1038/sj.bjc.6600836

  • O'Reilly, S M

    D C Talbot, V Moiseyenko, S Van Belle, S M O'Reilly, E Alba Conejo, S Ackland, P Eisenberg, D Melnychuk, T Pienkowski, H-U Burger, S Laws and B Osterwalder

    Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines

    doi:10.1038/sj.bjc.6600261

  • H E Innes, D B Smith, S M O'Reilly, P I Clark, V Kelly and E Marshall

    Oral antibiotics with early hospital discharge compared with in-patient intravenous antibiotics for low-risk febrile neutropenia in patients with cancer: a prospective randomised controlled single centre study

    doi:10.1038/sj.bjc.6600993

  • O'Reilly, T

    R A Spooner, F Friedlos, K Maycroft, S M Stribbling, J Roussel, J Brueggen, B Stolz, T O'Reilly, J Wood, A Matter, R Marais and C J Springer

    A novel vascular endothelial growth factor-directed therapy that selectively activates cytotoxic prodrugs

    doi:10.1038/sj.bjc.6600911

  • O'Sullivan, C

    P T K Saunders, M R Millar, K Williams, S Macpherson, C Bayne, C O'Sullivan, T J Anderson, N P Groome and W R Miller

    Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsies

    doi:10.1038/sj.bjc.6600035

  • O'Sullivan, G C

    A Houston, M W Bennett, G C O'Sullivan, F Shanahan and J O'Connell

    Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression

    doi:10.1038/sj.bjc.6601240

  • O'Sullivan, J M

    J M O'Sullivan, V R McCready, G Flux, A R Norman, F M Buffa, S Chittenden, M Guy, K Pomeroy, G Cook, J Gadd, J Treleaven, A Al-Deen, A Horwich, R A Huddart and D P Dearnaley

    High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone

    doi:10.1038/sj.bjc.6600348

  • O'Brien, M E R

    R H de Boer, I E Smith, U Pastorino, M E R O'Brien, F Ramage, S Ashley and P Goldstraw

    Pre-operative chemotherapy in early stage resectable non-small-cell lung cancer: a randomized feasibility study justifying a multicentre phase III trial

    doi:10.1038/sj.bjc.6690241

  • M E R O'Brien, A Saini, I E Smith, A Webb, K Gregory, R Mendes, C Ryan, K Priest, K V Bromelow, R D Palmer, N Tuckwell, D A Kennard and B E Souberbielle

    A randomized phase II study of SRL172 (Mycobacterium vaccae) combined with chemotherapy in patients with advanced inoperable non-small-cell lung cancer and mesothelioma

    doi:10.1054/bjoc.2000.1401

  • P V Murray, T Soussi, M E R O'Brien, I E Smith, S Brossault, A Norton, S Ashley and M Tavassoli

    Serum p53 antibodies: predictors of survival in small-cell lung cancer?

    doi:10.1054/bjoc.2000.1475